Tech Company Financing Transactions

Savara Pharmaceuticals Funding Round

On 10/6/2014, Savara Pharmaceuticals raised $10 million in funding from private investors.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Savara will use the additional financing to support the continued development of AeroVanc for people with CF who often struggle with persistent MRSA infection. In addition, the financing adds to our resources for corporate development as we look to expand our pipeline to prepare for Savara's next stage of growth.

Company Information

Company Status
Private & Independent
Mailing Address
6836 Bee Cave Rd. Building 3, 200
Austin, TX 78746
Email Address
Savara is a pharmaceutical company developing novel respiratory therapeutics utilizing our proprietary NanoCluster dry powder aerosol drug delivery platform.
Savara Pharmaceuticals LinkedIn Company Profile
Social Media
Savara Pharmaceuticals Company Twitter Account
Company News
Savara Pharmaceuticals News
Savara Pharmaceuticals on Facebook
Savara Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Robert Neville
  Robert Neville LinkedIn Profile  Robert Neville Twitter Account  Robert Neville News  Robert Neville on Facebook
Chief Financial Officer
David Lowrance
  David Lowrance LinkedIn Profile  David Lowrance Twitter Account  David Lowrance News  David Lowrance on Facebook
Chief Operating Officer
Taneli Jouhikainen
  Taneli Jouhikainen LinkedIn Profile  Taneli Jouhikainen Twitter Account  Taneli Jouhikainen News  Taneli Jouhikainen on Facebook
VP - Bus. Development
Peter Ginsberg
  Peter Ginsberg LinkedIn Profile  Peter Ginsberg Twitter Account  Peter Ginsberg News  Peter Ginsberg on Facebook
VP - Finance
Michael Ciesla
  Michael Ciesla LinkedIn Profile  Michael Ciesla Twitter Account  Michael Ciesla News  Michael Ciesla on Facebook
VP - General Counsel
Kate McCabe
  Kate McCabe LinkedIn Profile  Kate McCabe Twitter Account  Kate McCabe News  Kate McCabe on Facebook
VP - Regulatory Affairs
Cecilia Ganslandt
  Cecilia Ganslandt LinkedIn Profile  Cecilia Ganslandt Twitter Account  Cecilia Ganslandt News  Cecilia Ganslandt on Facebook
VP - Regulatory Affairs
Mette Vinge
  Mette Vinge LinkedIn Profile  Mette Vinge Twitter Account  Mette Vinge News  Mette Vinge on Facebook



Browse more venture capital transactions:

Prev: 10/6/2014: Tunespotter venture capital transaction
Next: 10/6/2014: Square venture capital transaction


Share this article


Where The Data Comes From

We do our best to record every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary